Related Experiment Video
Updated: May 3, 2026

09:03
Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
2.5K
Amplification-free CRISPR/Cas based dual-enzymatic colorimetric nucleic acid biosensing device
Guodong Tong1, Pabitra Nath2, Yuki Hiruta1
1Department of Applied Chemistry, Faculty of Science and Technology, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan. citterio@applc.keio.ac.jp.
Lab on a Chip
|January 8, 2025
Summary
A new 3D-printed biosensor uses CRISPR/Cas12a technology for fast, sensitive nucleic acid detection without amplification. This user-friendly device offers visual or quantitative DNA analysis, advancing point-of-care testing.
Area of Science:
- Biotechnology
- Biosensing
- Molecular Diagnostics
Background:
- Nucleic acid testing (NAT) is crucial but often complex, requiring specialized equipment and reagents.
- Existing NAT methods face limitations in user-friendliness, speed, and accessibility for field applications.
Purpose of the Study:
- To develop a fully integrated, 3D-printed biosensing device for user-friendly and highly sensitive nucleic acid detection.
- To utilize a CRISPR/Cas12a-based dual-enzymatic mechanism for amplification-free detection.
- To enable both visual and quantitative DNA analysis with smartphone compatibility.
Main Methods:
- A 3D-printed device incorporating a probe stick with gold nanoparticles for enhanced enzyme labeling.
- CRISPR/Cas12a system with alkaline phosphatase (ALP) conjugated via single-stranded DNA for signal generation.
- Development of a smartphone accessory for quantitative analysis and integration of all reagents.
Main Results:
- Achieved a limit of detection (LOD) as low as 10 pM for amplification-free colorimetric nucleic acid detection using the probe stick.
- The integrated device demonstrated a visual detection limit of approximately 100 pM.
- The system exhibited high specificity, successfully distinguishing between matched and mismatched nucleic acid sequences.
Conclusions:
- The developed 3D-printed biosensor offers a simple, portable, and sensitive platform for nucleic acid detection.
- This technology shows promise for rapid screening in clinical diagnostics, environmental monitoring, and food safety.
- The study advances the development of practical biosensors for point-of-care testing (POCT) applications.

